SUPN — Supernus Pharmaceuticals, Inc.

SUPNSupernus Pharmaceuticals, Inc.

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · supernus.com

47.96USD-0.52%Mkt Cap: 2.78B USDP/E: —Last update: 2026-05-26

Supernus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. It offers Qelbree…

Industry Peers

Drug Manufacturers - Specialty & Generic

SOBI

Swedish Orphan Biovitrum AB (publ)

155.29BSEKP/E 172.0

ECILC

EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.

United Therapeutics Corporation

Neurocrine Biosciences, Inc.

Indicators:|

Key Statistics

Company

Market Cap2.78B USD

Enterprise Value2.52B USD

Revenue (TTM)776.83M USD

Gross Profit644.39M USD

Net Income (TTM)-38.55M USD

Revenue/Share13.65 USD

Last Price47.96 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees778

CountryUS

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISINUS8684591089

Valuation

P/E (Trailing)—

P/E (Forward)11.31

PEG—

EV/EBITDA20.57

EV/Revenue3.25

P/S3.69

P/B2.67

EPS (TTM)-0.51

EPS (Forward)4.37

52W Range

30.8359% of range59.68

52W High59.68 USD

52W Low30.83 USD

Profitability

Gross Margin89.63%

Oper. Margin-3.58%

EBITDA Margin15.79%

Profit Margin-5.36%

ROE-3.63%

ROA-2.65%

Growth

Revenue Growth38.60%

Earnings Growth—

Cash Flow & Leverage

Operating CF47.33M USD

CapEx (TTM)1.34M USD

FCF Margin17.07%

FCF Yield4.78%

Net Debt-343.34M USD

Net Debt/EBITDA-2.80

Balance Sheet

Debt/Equity0.04

Current Ratio1.96

Quick Ratio1.51

Book Value/Sh18.48 USD

Cash/Share6.620 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)62.83 USD

Target Range55.00 USD – 66.00 USD

# Analysts6

Ownership

Shares Out.58.04M

Float52.12M

Insiders4.46%

Institutions103.92%

Short Interest

Short Ratio8.9d

Short % Float9.99%

Short % Out.8.13%

Shares Short4.72M

Short (prev mo.)4.53M

Technical

SMA 5049.95 (-4.0%)

SMA 20048.80 (-1.7%)

Beta0.57

S&P 52W Chg28.31%

Avg Vol (30d)670.04K

Avg Vol (10d)620.05K

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—